European Archives - Page 925 of 999 - European Medical Journal

Sperm Aneuploidy and DNA Integrity: A Review

Male factors leading to infertility account for at least half of all cases of infertility worldwide. The purpose of this review is to highlight the…

Sperm Motility and Viability: Overview of the Cellular and Physiological Aspects That Support These Functions

This review briefly summarises the cellular and physiological aspects of sperm motility (SM) and viability from the point of view of male…

Fertility Preservation in Patients with Endometrial Cancer

Endometrial carcinoma (EC) is the most common gynaecological cancer, with 2-14% of cases occurring in women <40 years of age.

New Concepts in the Therapeutic Management of Myoma

The therapeutic management of symptomatic uterine fibroids is based on three pillars: surgery, pharmacotherapy, and interventional radiotherapy.

Role of Nuclear Receptors in Spontaneous and Recurrent Miscarriage

Although early pregnancy loss is a common complication of human reproduction, a significant proportion of miscarriages still happen for unknown reasons.

The Epidemic of Twins: The Challenge in Obstetrics and Gynaecology

In the past 50 years, the incidence of multiple pregnancy has increased dramatically due almost exclusively to two factors: delayed childbearing and…

EMJ Reproductive Health 1.1 2015

Hello and a warm welcome to the very first edition of EMJ Reproductive Health, a brand new resource bringing you the latest developments and innovations…

EMJ

‘Artificial Pancreas’ Could Revolutionise Control of Type 1 Diabetes

IMPLANTABLE ‘artificial pancreas’ may eliminate the use of insulin injections and pumps for individuals with Type 1 diabetes (T1D), potentially…

EMJ

Genetic Variation Affects Potency of Anti-Diabetic Drug

EFFECTIVENESS of an anti-diabetic drug depends on small, natural differences in DNA among individuals, a discovery that has paved the way…

Thrombosis in Haematological Disorders: Tailored Management Approaches

The meeting commenced with a talk from Prof Anna Falanga on the management of thrombosis in both onco-haematological and non-oncological diseases.